Startseite>>Signaling Pathways>> PROTAC>>N-(2-Aminoethyl)maleimide (trifluoroacetate salt)

N-(2-Aminoethyl)maleimide (trifluoroacetate salt) (Synonyms: 2-Maleimidoethylamine)

Katalog-Nr.GC47717

Mal-NH2 (TFA) ist ein Alkylketten-basierter PROTAC-Linker, der bei der Synthese von PROTACs verwendet werden kann.

Products are for research use only. Not for human use. We do not sell to patients.

N-(2-Aminoethyl)maleimide (trifluoroacetate salt) Chemische Struktur

Cas No.: 146474-00-2

Größe Preis Lagerbestand Menge
250 mg
153,00 $
Auf Lager
500 mg
290,00 $
Auf Lager
1 g
427,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

N-(2-Aminoethyl)maleimide is a thiol-reactive cross-linking agent.1,2 It has been used in the synthesis of maleimide-functionalized heparin hydrogels in the development of growth factor delivery systems and radiotracers for thiol-mediated protein labelling.

1.Nie, T., Baldwin, A.C., Yamaguchi, N., et al.Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systemsJ. Control Release122(3)287-296(2007) 2.Kratz, H., Haeckel, A., Michel, R.P., et al.Straightforward thiol-mediated protein labelling with DTPA: Synthesis of a highly active 111In-annexin A5-DTPA tracerEJNMMI Res.2(1)17(2012)

Bewertungen

Review for N-(2-Aminoethyl)maleimide (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N-(2-Aminoethyl)maleimide (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.